The U.S. Drug Enforcement Administration collected more than 19,000 pounds of unused and expired medication across the Midwest during its spring Prescription Drug Take Back Day. The event marks an annual cleanout that helps keep leftover prescription opioids and other drugs out of the wrong hands. 

For families worried about opioid addiction in their own home, the event is a reminder of a simple risk-reduction step. Painkillers left in a medicine cabinet are a common starting point for misuse.

All About Take Back Day

On April 25, the DEA and 4,300+ law enforcement agencies nationwide collected 642,410 pounds of unneeded medication at the 30th National Prescription Drug Take Back Day. More than 19,000 pounds came from 159 collection sites throughout the DEA’s Omaha Field Division that covered Iowa, Minnesota, Nebraska, North Dakota and South Dakota.

Special Agent Dustin Gillespie is in charge of the DEA Omaha Field Division. He credited local partners who help coordinate drop-off sites for the program’s reach. Gillespie noted how local support allows community members to safely clear unwanted medication from their homes and keep these substances out of their neighborhoods.

Since the program began in 2010, it has collected 21,034,225 pounds of medication nationwide, the equivalent of more than 10,500 tons. Residents of the five Omaha Field Division states have contributed 725,265 of those pounds.

Leftover Prescription Opioids Matter

Prescriptions such as oxycodone and hydrocodone remain central to the overdose crisis. Many people who develop opioid addiction first encounter these drugs through a legitimate prescription. But pills left over after an injury or surgery can be misused, taken by a family member, or diverted to someone else. 

Clearing them out lowers the risk of accidental poisoning, particularly for children. Disposing of these narcotics also removes a future stash that can fuel misuse. 

The DEA says the take-back program is built to prevent prescription drug misuse and reduce accidental overdoses and poisonings.

Year-Round Drug Disposal Options

People who missed the April event don’t have to wait for the next one. The DEA points to more than 16,500 pharmacies, hospitals, businesses and police departments that accept unused medication year-round, along with permanent drop boxes listed on its Every Day is Take Back Day resource. 

Gillespie encouraged residents to locate a year-round site and dispose of medication regularly rather than letting it be a one-and-done event in the household. Other practical tips to avoid exposure and addiction include coordinating with your doctor and seeking alternatives to opioids in the first place.

Harm Reduction Tactics

Disposing of unused pills is one piece of a larger response to the opioid crisis. In homes where opioid use already takes place, naloxone (sold as Narcan) can reverse an opioid overdose and can be bought at most pharmacies without a prescription. Fentanyl test strips can help detect the synthetic opioid that now drives most overdose deaths. 

For ongoing opioid addiction, medication-assisted treatment (MAT) remains among the most strongly evidence-based options. Therapists often combine MAT with counseling and peer support groups such as Narcotics Anonymous.

Help & NA meetings

Narcotics Anonymous offers free, peer-led support for people recovering from drug addiction, with meetings available in person and online across all five Midwest states and nationwide. If you or someone you love wants to stop an addiction to prescription opioids or other drugs, treatment options range from outpatient counseling to medical detox and inpatient care. 

Call 800-934-1582(Sponsored) to chat with a specialist. Feel free to also look through our directory of verified listings for NA chapters anywhere in the USA.

The fentanyl crisis has left a trail of grieving families across Louisiana, and some of them now turn that grief into prevention. To be clear, the Bayou State already offers many programs to combat substance abuse, from neighborhood Narcotics Anonymous chapters to modern inpatient medical programs. Despite the many successes, the toll remains large.

Now, individuals and families fight back. Mo’s Movement, founded by a mother who lost her daughter to a fentanyl overdose, aims to help other families tell their stories, push for awareness and point people toward opioid addiction help before another life is lost.

A Mother’s Loss Behind the Movement

Angela Shockley started Mo’s Movement in 2024 after her daughter Morgan, known as “Mo,” died of a fentanyl overdose in March 2023 at age 31. Over nine years, Morgan went through 17 inpatient treatment programs before her death. Shockley founded the group as a drug prevention and awareness program for families who’ve lived through the same loss. She works alongside Janet Daigle, whose daughter Gabrielle died of a fentanyl overdose in April 2024 at age 28.

Mo’s Movement comes at a time when the number of opioid deaths are waning, but the crisis is still far from over. Fentanyl is a synthetic opioid far stronger than heroin. Officials have found fentanyl mixed into many street drugs, often without the user’s knowledge. 

Since such a small amount of fentanyl can kill, overdoses often happen fast. Naloxone, sold as Narcan in a 4 mg dose and Kloxxado in an 8 mg dose, can reverse an opioid overdose if given quickly. Users can find naloxone for free in many communities. Nevertheless, overdoses still happen. Each time, a family grieves.

The Empty Chair Project

One of the group’s most visible efforts is the Empty Chair Project. Here, volunteers set out one chair for each person who died of an overdose in a given parish or county over the past year. The chairs are decorated in purple, the color of drug awareness. 

In Tangipahoa Parish, 38 overdose deaths from the past year plus four confirmed in early 2026 added up to 42 chairs placed on the lawn of a chapel at the Rosaryville Retreat Center. At the site, filmmaker Glen Muse of Texas Pictures has been documenting parents’ stories to generate further awareness.

Signs of Progress in Hard-Hit Parishes

Both mothers describe how shame keeps people with a substance use disorder from getting help. Shockley pointed out that guilt and embarrassment remain the fastest ways to push someone back into active use. She also stressed that addiction is a medical condition, not a failure of willpower. Daigle recalled how some medical providers treated her daughter differently once they learned she used drugs, a reaction that can deepen isolation.

Some Louisiana communities now see fewer deaths. Washington Parish, once ranked among the highest in the country for overdoses per capita, recorded a drop to 41 deaths in 2024 and seven in 2025. In Tangipahoa Parish, Sheriff Gerald Sticker pointed to a 45% decrease in fentanyl-related deaths. Sticker also singled out programs like Operation Angel, which connects people with addiction to treatment instead of jail. Incarceration alone doesn’t solve the problem.

Help for Opioid Addiction in the USA

Recovery from opioid addiction takes many forms, including medication for opioid use disorder, counseling, and peer support such as Narcotics Anonymous. For families and individuals looking for a next step, NA meetings offer free, ongoing peer support, and many areas now host both in-person and virtual options.

Getting started is simple. Just call 800-934-1582(Sponsored) or browse our directory for NA locations anywhere in the country alongside other treatment programs.

Twenty Kentucky counties are banding together to tackle the opioid crisis head-on, and they have nearly $1 billion in settlement money to work with.

The Kentucky Association of Counties (KACo) has launched its Opioid Solutions Network, a first-of-its-kind cohort designed to help local governments turn settlement funds into real, on-the-ground recovery programs that reach people struggling with opioid addiction before it’s too late.

The Opioid Crisis by the Numbers in Kentucky

Kentucky has long ranked among the hardest-hit states in the national opioid epidemic. The commonwealth is set to receive approximately $1 billion in opioid settlement funds as part of the National Settlement Agreement

It was a nearly $50 billion nationwide payout from pharmaceutical manufacturers and distributors held accountable for their role in fueling opioid abuse across the country.

Half of those settlement dollars flow to the state government, while the remaining half goes directly to local counties for allocation.

The problem, according to KACo Opioid Settlement Advisor Lauren Carr, is that not every county has the staff, expertise, or infrastructure to spend that money effectively.

“All 120 counties receive opioid settlement funds, but a lot of counties are different,” Carr said. “Some have the capacity to attack this, and some don’t, so we’re trying to break down the information and make it easily digestible in ways they can understand so they can put it into action in their community.”

That’s exactly what the 20-county cohort, which includes both Graves County and Trigg County in western Kentucky, is designed to fix.

What’s Driving the Network’s Formation

The opioid crisis does not affect every community the same way. Rural counties in particular often lack the public health infrastructure to identify the most effective interventions for narcotic addiction, navigate grant compliance requirements, or build the multi-agency partnerships that recovery experts say are essential.

KACo’s cohort offers member counties a structured framework for doing all of that. Carr said the network will push participating counties toward earning Kentucky’s “Recovery Ready Community” certification.

It’s a state designation requiring counties to demonstrate they can provide prevention, treatment, and sustained support services for people dealing with opioid addiction or other substance use disorders.

Only 39 of Kentucky’s 120 counties currently hold that certification, including McCracken County, which earned it in 2024.

Peer Recovery and Community-Based Treatment

On the ground, organizations like the Turning Point Recovery Community Center in McCracken County are already demonstrating what settlement funding can accomplish.

Site Administrator Nathan Brockett said collaboration with neighboring counties played a major role in Turning Point’s ability to earn Recovery Ready certification, and that the settlement dollars have opened doors that weren’t available before.

“We utilize that funding to create our mobile access to recovery program,” Brockett said. “We’re able to literally meet people where they’re at.” Turning Point used opioid abatement funding to purchase a van for mobile outreach, allowing recovery specialists to reach individuals with opioid addiction who might never walk through a clinic door.

Brockett added that the flexible nature of opioid abatement funds has allowed Turning Point to expand programming far beyond a single intervention. “The opioid abatement funding doesn’t make us so constrained,” he said.

“They allow us to be able to do so many different things.” The organization now has more ways to connect people struggling with narcotic addiction to treatment, peer support, and ongoing recovery services.

Understanding Opioid Addiction and Overdose Risk

Opioids are a class of drugs that include prescription pain medications, heroin, and synthetic opioids like fentanyl. They work by binding to receptors in the brain and body, producing pain relief and, at higher doses, respiratory depression that can lead to fatal overdose.

Fentanyl, now present in much of the illicit drug supply, is up to 100 times more potent than morphine, making accidental overdose a constant risk even for people who believe they are taking a different substance.

Naloxone (brand name Narcan) is a medication that rapidly reverses an opioid overdose and is available without a prescription at most pharmacies in Kentucky. Carrying naloxone is one of the most effective harm reduction steps anyone can take.

Finding Help for Opioid Addiction in Kentucky

For anyone in Kentucky dealing with opioid addiction or narcotic addiction, recovery resources are available:

NA Meetings in Kentucky — Narcotics Anonymous holds meetings across the state, including in Paducah, Mayfield, and surrounding western Kentucky communities. Find a meeting near you at na.org or search “NA meetings near me.”

Opioid Treatment Programs Near You — Medication-assisted treatment (MAT) with buprenorphine or methadone is available through licensed providers across Kentucky. Contact SAMHSA’s National Helpline at 1-800-662-4357 (free, confidential, 24/7) for opioid addiction treatment options near you.

Recovery Ready Communities — Kentucky’s certified Recovery Ready counties maintain directories of local prevention, treatment, and peer support services. Ask your county health department or visit the Kentucky Opioid Abatement Advisory Commission website for resources.

If you or a loved one needs support with recovery, you can search Narcotics.’com’s directory to find NA meetings in your area. Call 800-934-1582(Sponsored) to speak with a treatment advisor today.

The fentanyl crisis just got more dangerous. A new federal advisory warns that fentanyl, the leading driver of overdose deaths in the United States, is increasingly being cut with a new class of synthetic substances that can overwhelm standard overdose reversal treatments.

For anyone struggling with opioid addiction, or anyone who loves them, this is a life-or-death update.

The Opioid Crisis by the Numbers

The opioid epidemic has claimed more than 500,000 American lives over the past two decades, and fentanyl has been central to that toll for years.

Now, the DEA is warning that the illicit drug supply is becoming even more unpredictable as new synthetic compounds enter the market alongside fentanyl.

Public health officials and law enforcement agencies are increasingly encountering fentanyl mixed with powerful substances such as xylazine, medetomidine, nitazenes, and cychlorphine.

Many of these compounds are not approved for human use and are often impossible for users to detect. Since 2020, the Drug Enforcement Administration (DEA) has identified 22 unique nitazene compounds, 21 of which are now classified as Schedule I controlled substances.

That rapid proliferation signals how quickly the illicit opioid supply is evolving, and how hard it is for users, families, and first responders to keep up.

What Is Driving the Fentanyl Contamination Trend

The drivers behind these new mixtures are both chemical and criminal. New nitazenes tend to be introduced when regulatory actions, enforcement, and drug scheduling put pressure on existing analogues, meaning that as authorities crack down on one synthetic opioid, traffickers pivot to the next. It is a cycle that has defined the opioid crisis for years, and it is accelerating.

Xylazine and medetomidine are veterinary sedatives used to sedate animals, while nitazenes and cychlorphine are potent, unregulated synthetic opioids.

None of these substances were designed for human consumption. None carry dosing guidance. And none appear visibly different when mixed into a pill or powder.

These substances are frequently mixed into counterfeit pills or fentanyl powder without the user’s knowledge. For someone managing narcotic addiction in an active use environment, there is often no way to know what is in a substance before taking it.

Fentanyl’s Role in the Evolving Drug Supply

Fentanyl remains the anchor of the overdose crisis, but it is now a delivery vehicle for an ever-changing cocktail of synthetic drugs. These emerging synthetic drugs can be significantly more powerful than fentanyl and greatly increase the risk of a fatal overdose.

That potency matters enormously for anyone carrying naloxone (Narcan), the medication that reverses opioid overdoses and has saved countless lives.

Drugs like xylazine and medetomidine are not opioids, meaning naloxone may not fully reverse their effects, complicating overdose response. Other synthetics, such as nitazenes and cychlorphine, might require several doses of naloxone to be effective.

In practical terms: naloxone is still essential and should always be used, but a single dose may no longer be enough, and calling 911 immediately is critical.

Understanding the Overdose Risk

Opioid addiction involves physical dependence on substances that act on the brain’s opioid receptors, causing slowed breathing that can become fatal during an overdose. Fentanyl is roughly 100 times more potent than morphine.

The new synthetic compounds now appearing alongside fentanyl in the illicit drug supply can be even more potent, and some, like xylazine, cause additional harm that naloxone cannot address.

Xylazine has been linked to devastating soft tissue damage, infections, and prolonged sedation, while other synthetics can cause rapid respiratory depression and death.

Harm Reduction and Treatment Options

The DEA’s advisory reinforces several harm reduction principles that can save lives right now:

Carry naloxone. Given that some synthetics require multiple administrations, having two or more doses on hand is now a practical necessity. Narcan nasal spray is available without a prescription at most pharmacies and through community distribution programs.

Use fentanyl test strips. While they cannot detect every adulterant, fentanyl test strips are a critical harm reduction tool for identifying contaminated substances before use.

Never use alone. A witness who can call 911 and administer naloxone is your best chance of surviving an overdose involving these new synthetic combinations.

Medication-assisted treatment (MAT) works. Buprenorphine (Suboxone) and methadone are FDA-approved treatments for opioid addiction that dramatically reduce overdose risk. A provider can connect you with options in your area.

NA meetings offer peer support. Narcotics Anonymous provides free, community-based recovery support for people struggling with opioid abuse and narcotic addiction. Meetings are available in person and online every day.

Finding Help for Opioid Addiction

If you or someone you love is struggling with opioid addiction or narcotic addiction, help is available right now. Search narcotics.com’s directory to find NA meetings near you. You can also call 800-934-1582(Sponsored) to speak with a treatment advisor.

A new and more potent fentanyl analog in a rural New Mexico town has left three people dead and nearly two dozen first responders hospitalized. The tragedy offers a stark warning about where the opioid crisis is heading. 

While New Mexico boasts a wide range of treatment programs, from local Narcotics Anonymous chapters to modern residential facilities, The Land of Enchantment still faces large numbers of overdoses and fatalities. The May 20 incident in Mountainair has shaken the public health community and raised urgent questions about the evolving dangers of synthetic opioids in the illicit drug supply.

The Opioid Crisis Mounts in Mountainair

Three individuals died and 18 first responders went to the hospital after exposure to an unknown substance at a Mountainair home. What initially appeared to be a routine overdose call quickly became a mass-casualty event. New Mexico State Police confirmed that 25 people in total were exposed to a combination of fentanyl, methamphetamine, and para-fluorofentanyl, all in powder form. Of those 25, 20 were taken to hospital.

Officials pronounced two victims dead at the scene. Another died after arriving at the University of New Mexico Hospital. A fourth person found unconscious at the home survived. Both the survivor and one of the deceased had been administered Narcan before emergency crews arrived.

Two people — one a first responder — remained hospitalized as of Friday, May 22. 

Para-Fluorofentanyl and Why It Matters

The most alarming part of this opioid tragedy is the confirmed presence of para-fluorofentanyl, commonly called P4 fentanyl. New Mexico State Police Chief Matt Broom described it as “a more illicit form or version of fentanyl” during a press conference.

Fentanyl is a synthetic opioid that’s up to 100x stronger than morphine. It’s now dominant in the majority of illicit drug supplies across the United States, often mixed into other substances without users’ knowledge. 

Para-fluorofentanyl and other fentanyl analogs do what regular fentanyl does: bind to opioid receptors and suppress breathing. But these new variants may be harder to reverse with standard doses of naloxone. That’s because analogs like P4 fentanyl are specifically engineered to evade detection by standard drug tests and may be even more potent than the fentanyl already responsible for the majority of overdose deaths in the United States.

The three deaths in Mountainair represent a fraction of the more than 70,000 Americans who died from drug overdoses in 2025. But the mass exposure of first responders makes this incident a signal event for the direction of the opioid epidemic.

Fentanyl’s Role in First Responder Exposure

A doctor who witnessed the first responders showing symptoms like nausea and dizziness said their symptoms closely resembled fentanyl exposure. University of New Mexico Hospital CMO Steve McLaughlin reported that they’re now assuming that fentanyl was the culprit behind the tragedy.

Torrance County Fire officials noted firefighters didn’t wear hazmat gear because the situation didn’t initially require it. Officials will now review response procedures going forward. Nevertheless, that detail underscores how quickly a fentanyl exposure scene can overwhelm standard emergency protocols and the necessity for first responders and the public to know the risks of synthetic opioids in powdered form.

Investigators believe the exposure occurred through contact and not by air. This critical distinction helped reassure the surrounding community, though it didn’t diminish the severity of the exposure event.

Harm Reduction and Treatment for Opioid Addiction

Events like Mountainair make clear that naloxone (Narcan) saves lives, but that the evolving fentanyl supply demands higher vigilance. Public health officials recommend:

• Carrying and knowing how to use naloxone. Multiple doses may be required for fentanyl analog overdoses.

• Never use drugs alone. The four people found in the Mountainair home had no one to call for help until a co-worker raised the alarm.

• Fentanyl test strips, which can detect the presence of standard fentanyl, though analogs like P4 may require updated testing protocols.

• Medication-assisted treatment (MAT) with Suboxone or methadone remains the most effective long-term intervention for opioid addiction and narcotic dependence.

Help for Opioid Addiction in New Mexico

If you or someone you love has an opioid addiction or narcotic dependence, help is available right now.

Narcotics Anonymous holds in-person and online meetings throughout New Mexico. NA meetings provide free, peer-led support for anyone dealing with narcotic addiction — no cost, no referral required. 

Just dial 800-934-1582(Sponsored) to speak with an expert or look through our directory for any NA meeting located in the country.

Philadelphia is on the verge of a milestone in its fight against the opioid overdose crisis, but health officials warn that a rising stimulant threat and persistent gaps in the recovery pipeline demand continued urgency.

In 2024, there were 1,069 overdose fatalities in Philadelphia, an 18% decrease from 2023 and a 24% drop from the all-time peak of 1,413 deaths recorded in 2022.

Preliminary state data suggest deaths may fall further still, to 921 in 2025, which would mark the first time Philadelphia has recorded fewer than 1,000 overdose fatalities in nearly ten years.

For Pennsylvanians seeking opioid treatment or NA meetings in Philadelphia, the data offers real encouragement, alongside a clear-eyed warning about what’s next.

The Opioid Crisis by the Numbers in Philadelphia

Since 2020, 6,281 people have fatally overdosed in Philadelphia. The back-to-back annual declines represent a meaningful reversal after years of record-setting death tolls, but officials stress the work is nowhere near finished.

Experts credit a combination of factors for the decline: broader community outreach, improved access to opioid treatment and shifts in the local drug supply.

As the city’s director of Substance Use Prevention and Harm Reduction, Daniel Teixeira da Silva, put it: “Overdoses are not going down for everyone.” Certain neighborhoods and populations continue to see higher concentrations of opioid-related deaths, underscoring that citywide progress does not mean uniform progress.

What Is Driving the Decline in Opioid Overdose Deaths

A standout factor in Philadelphia’s turnaround has been aggressive, boots-on-the-ground naloxone distribution. City officials credited a 2024 program through the Overdose Response Unit that delivered naloxone, the opioid-overdose-reversing medication sold under the brand name Narcan.

Medication was delivered to neighborhoods with high concentrations of overdose deaths. This included parts of North Philadelphia where fatalities had been climbing for years.

Workers knocked on hundreds of thousands of doors offering the medication to residents in communities that had historically received fewer harm reduction resources.

Expanded access to medication-assisted treatment for opioid addiction, combined with peer outreach and NA meeting networks, has also contributed to connecting more people with sustained recovery support.

Fentanyl Still Dominates but Stimulants Are Rising

Fentanyl remains the engine of Philadelphia’s overdose crisis. In 2024, 77% of all overdose deaths involved opioids, with illicit fentanyl at the center of most cases.

But a dangerous new pattern is emerging alongside the opioid epidemic: stimulant-involved deaths are climbing even as opioid fatalities fall.

In 2024, opioids and stimulants were co-detected in 50% of all overdose deaths. Deaths involving stimulants but no opioids increased 8.6% from 2023 to 2024.

Adulterants are compounding the danger further. Xylazine, a veterinary sedative increasingly mixed into street opioids, was detected in 34% of all overdose deaths in 2024. A newer veterinary sedative, medetomidine, was found in 9% of overdose deaths after the Medical Examiner’s Office began testing for it in May 2024.

These additives are particularly deadly because naloxone does not reverse their sedative effects, meaning a person can be revived from opioid overdose and still die from xylazine- or medetomidine-induced respiratory failure without further intervention.

Understanding Opioid Addiction and Overdose Risk

Opioids, including fentanyl, heroin, and prescription painkillers, suppress the central nervous system and can stop breathing entirely during an overdose.

Fentanyl is 50 to 100 times more potent than morphine, making accidental overdose especially likely when it contaminates other substances. Naloxone (Narcan) rapidly reverses opioid overdose and is available without a prescription at most Pennsylvania pharmacies.

Harm Reduction and Treatment for Opioid Addiction

Philadelphia’s progress proves that harm reduction and opioid treatment save lives at scale. For anyone struggling with opioid abuse or narcotic addiction, effective options include:

Naloxone/Narcan — Free at many Philadelphia-area pharmacies, health clinics, and city harm reduction sites. Every household should have it.

Medication-Assisted Treatment (MAT) — Buprenorphine (Suboxone) and methadone are FDA-approved treatments for opioid addiction that significantly reduce overdose risk and support long-term recovery.

Fentanyl Test Strips — Legal in Pennsylvania and available through harm reduction programs, these allow people to screen substances for fentanyl contamination.

Narcotics Anonymous — NA meetings offer free, peer-based recovery support for anyone dealing with narcotic addiction, with no requirement to be in formal treatment.

You can search narcotics.com’s directory to find NA meetings in your area. Call 800-934-1582(Sponsored) to speak with a treatment specialist today.

The city of Nashville has filed a lawsuit against supermarket chain Publix, alleging the retailer played a direct role in fueling the opioid epidemic that has devastated Tennessee communities for more than a decade.

For the tens of thousands of people struggling with opioid addiction across the state, and the families who have lost loved ones, the lawsuit represents a rare legal reckoning with the supply chain that made prescription opioids widely available and widely abused.

The Opioid Crisis by the Numbers in Tennessee

Tennessee has the third highest rate of opioid prescriptions in the United States. That ranking did not happen by accident, it reflects years of oversupply by distributors, pharmacies, and prescribers alike.

In 2016, Tennessee recorded 1,631 overdose deaths. While that figure is now nearly a decade old, the trend it set in motion has only worsened.

The city’s lawsuit notes that while opioid prescriptions are slightly declining, adverse health outcomes including overdoses, Neonatal Abstinence Syndrome, and mortality rates are not improving, and that opioid and heroin deaths in Nashville have increased drastically.

Neonatal Abstinence Syndrome, a condition in which newborns experience withdrawal symptoms after prenatal opioid exposure, is one of the most sobering consequences of the epidemic, and its persistence signals that opioid addiction continues to affect the most vulnerable populations.

What Nashville Claims Publix Did

According to the lawsuit, Nashville alleges that Publix helped fuel the oversupply and diversion of prescription opioids, which in turn drove up costs for first responders, hospitals, law enforcement and homelessness and mental health services.

The city is seeking financial compensation and is asking Publix to stop or fix the problem.

The suit is part of a broader national wave of opioid litigation that has already resulted in multi-billion-dollar settlements with pharmaceutical manufacturers and distributors, accountability efforts that public health advocates say are critical to funding long-term treatment and recovery infrastructure.

What Drives Prescription Opioid Abuse

Opioids are a class of drugs that include prescription painkillers such as oxycodone and hydrocodone, as well as illicit substances like heroin and illicitly manufactured fentanyl.

They work by binding to receptors in the brain and body to reduce pain, but they also produce intense euphoria and carry a high risk of physical dependence and opioid addiction.

The prescription opioid pipeline that Nashville’s lawsuit targets was, for many people, the on-ramp to addiction. Research consistently shows that a significant share of people who develop heroin addiction first became dependent on prescription opioids.

As prescriptions became harder to obtain, many people transitioned to heroin, and more recently, to fentanyl, a synthetic opioid estimated to be 50 to 100 times more potent than morphine.

Fentanyl’s Role in Today’s Opioid Epidemic

Even as prescription opioid rates edge downward, the opioid epidemic has entered a deadlier phase driven by illicitly manufactured fentanyl.

Fentanyl is now the leading cause of overdose deaths in the United States, and it is increasingly found mixed into counterfeit pills, cocaine and other substances, meaning people may be exposed without knowing it.

Naloxone (brand name Narcan) is a life-saving medication that can reverse an opioid overdose within minutes.

It is available without a prescription at most pharmacies in Tennessee and through community harm reduction organizations. Anyone living with or caring for a person with narcotic addiction should have naloxone on hand and know how to use it.

Treatment and Recovery Options for Opioid Addiction

If you or someone you love is struggling with opioid abuse or narcotic addiction, effective treatment exists, and recovery is possible. Search Narcotics.com’s directory for nearby NA meetings. You can also call 800-934-1582(Sponsored) to speak with a treatment specialist.

A new animal sedative known as “rhino tranq” is showing up in the illegal fentanyl supply across the United States, and it is making opioid overdoses harder to reverse and withdrawal more dangerous than ever.

For anyone struggling with narcotic addiction or opioid abuse, this threat demands urgent attention. The CDC, alongside the White House Office of National Drug Control Policy, issued a Health Advisory on April 2, 2026.

They warned public health professionals, clinicians and people at risk for overdose about rising reports of medetomidine, known on the street as “rhino tranq,” “mede,” or “dex”, appearing in the illegal drug supply. The drug is not approved for human use; it is approved for sedation in dogs.

Rhino Tranq Is Spreading Fast Through the Fentanyl Supply

The number of medetomidine detections reported to the National Forensic Laboratory Information System jumped 950% from 247 in 2023 to 2,616 in 2024, followed by a further 215% increase to 8,233 in 2025.

That is an explosive trajectory for a drug most people, including many clinicians, have never heard of. The geographic spread appears to be concentrated in the Northeast (52%) and Midwest (31%), followed by the South (17%) and the West (under 1%).

But fentanyl does not stay put, and neither does what gets mixed into it. Among drug product samples that tested positive for medetomidine between July and December 2025, 98% also had fentanyl co-detected.

It confirms that rhino tranq is being deliberately blended into what is sold as fentanyl. People using street opioids have no way of knowing it is there.

Why This Makes Fentanyl Even More Dangerous

Fentanyl is already the leading driver of overdose deaths in the United States. Adding medetomidine to the mix creates two new, compounding dangers: a harder-to-reverse overdose and a potentially life-threatening withdrawal syndrome.

Medetomidine can cause profound sedation, severe slowing of the heart rate, and dangerously low blood pressure. Stopping the drug after regular use can trigger severe withdrawal, similar to clonidine withdrawal.

Symptoms include high blood pressure, anxiety, nausea, vomiting, and fluctuating alertness that may require emergency or intensive care.

A May 2024 overdose cluster in Chicago linked to medetomidine involved 12 confirmed, 26 probable, and 140 suspected overdoses. Fentanyl was detected in all medetomidine-positive samples. At least 16 people were hospitalized and one person died.

Naloxone Is Still Essential But Has Limits

Naloxone (Narcan) remains the first-line response to any suspected opioid overdose, and that does not change with medetomidine in the picture.

Because fentanyl is involved in nearly all medetomidine-associated overdoses, opioid overdose reversal medications like naloxone should be administered in suspected overdoses to restore normal breathing.

However, naloxone can reverse the opioid component and restore breathing, but it will not reverse medetomidine’s sedating effects, meaning a person may still remain deeply unconscious even after naloxone is given.

The CDC recommends repeating naloxone every 2–3 minutes as needed to keep the person breathing at least once every 5 seconds, and placing the person in the recovery position with the airway clear. Call 911 immediately after administering naloxone.

What Rhino Tranq Withdrawal Looks Like

Medetomidine withdrawal symptoms can include rapid heart rate, severe high blood pressure, fluctuating alertness, tremor, chest pain, and intractable nausea and vomiting. Symptoms may begin within hours of last use and peak 18–36 hours later.

Serious complications including heart attack and a brain condition called posterior reversible encephalopathy syndrome have been associated with severe medetomidine withdrawal.

If you or someone you know is experiencing these symptoms after stopping opioid use, go to an emergency room immediately or call 911. This is not a withdrawal that can safely be managed at home.

Understanding Opioid Addiction and Narcotic Dependence

Opioids, including fentanyl, heroin and prescription painkillers, are highly addictive substances that create physical dependence rapidly. Fentanyl is 50 to 100 times more potent than morphine, which is why even a tiny amount of it can be lethal.

Narcotic addiction changes brain chemistry in ways that make stopping without support extremely difficult and, as this new data shows, physically dangerous.

Naloxone can reverse an overdose in the moment, but medication-assisted treatment and peer recovery are what sustain long-term survival.

Finding Help for Opioid Addiction

If you or someone you love is struggling with fentanyl, heroin addiction, or opioid abuse, help is available right now. Explore Narcotics.com’s directory to find NA meetings near you. You can also call 800-934-1582(Sponsored) to learn more about your treatment options.

For decades, West Virginia has been synonymous with the opioid crisis, but now, death rates decline for the first time in a generation. Lives are being saved, but officials warn that the trend might not last.

According to March 2026 data from the Centers for Disease Control and Prevention, fatal drug overdoses in The Mountain State have plummeted more than 48% over the previous year — a decline that substantially exceeds the national average of 44%. 

To be sure, officials and residents have made strides to combat substance misuse. From local Narcotics Anonymous chapters to modern inpatient facilities, West Virginians made a genuine turning point in the opioid crisis. For a state that has long carried the heaviest overdose burden in the country, each falling stat means one more life saved.

Opioids in West Virginia

The scale of West Virginia’s suffering has never been in dispute. Between 2019 and 2023, the state recorded an average overdose death rate of 187 per 100,000 residents aged 35 to 44. The numbers were nearly 192% above the national average of 64 deaths per 100,000.

From February 2025 to 2026, 766 West Virginians died from drug overdoses, compared to 1,331 in 2024. While that number still represents devastating loss, the trajectory is unambiguous.

Nationally, provisional CDC data indicates a 44% decline in overdose deaths since the August 2023 peak. It’s  the longest sustained decrease in more than four decades. 

Driving the Opioid Crisis Down

Officials point to several converging factors behind West Virginia’s mortality reduction: a better public understanding of drug dangers, an expansion in opioid treatment access, and widespread naloxone distribution. They work in tandem rather than in isolation.

The state’s medication-assisted treatment (MAT) infrastructure has expanded significantly for individuals with opioid use disorder. Harm reduction programs have distributed thousands of naloxone kits to create safety nets before overdoses become fatal. In 2023 alone, the state’s Department of Human Services distributed 97,780 naloxone kits.

Education campaigns have also shifted public understanding of addiction. Where previous messaging often emphasized criminalization and moral failure, newer approaches frame substance use disorder as a medical condition requiring treatment, which reduces stigma and encourages help-seeking behavior.

Fentanyl’s Role in the Opioid Epidemic

Fentanyl remains the central driver of opioid deaths in West Virginia and across the country. Fentanyl and its analogues were involved in 76% of overdose deaths in West Virginia in 2021, even as the proportion of deaths involving heroin declined sharply. 

Now, a new threat is compounding the fentanyl crisis. Xylazine is a veterinary tranquilizer known on the street as “tranq” and has increasingly appeared mixed with fentanyl. The drug isn’t approved for human use and extends the effects of opioids but creates a dangerous complication. Naloxone does not reverse xylazine overdoses. Public health officials in West Virginia are actively monitoring its spread. 

Progress is Real But Fragile

West Virginia’s steep decline places it among the most successful states in reducing overdose mortality, but officials emphasize that the crisis is far from over. Even with dramatic improvements, the state continues to lose hundreds of residents annually to drug-related deaths.

One researcher who has studied the state’s progress expects rates to remain stable before potentially rising again over the next two years. Current gains could plateau or reverse. Proposed federal budget cuts threatening SAMHSA-funded programs have added urgency in other states and also among West Virginian officials. 

Harm Reduction and Opioid Treatment Options

If you or someone you love is struggling with narcotic addiction or opioid abuse, effective treatment exists. Options include:

MAT: Buprenorphine (Suboxone), methadone and naltrexone are FDA-approved prescriptions to reduce cravings and withdrawal.

Naloxone/Narcan Access: Naloxone is available free or low-cost through many West Virginia harm reduction programs, pharmacies and health departments. Carry and use it to save lives.

Fentanyl Test Strips: These low-cost tools allow people to test substances for the presence of fentanyl before use and are increasingly available through harm reduction organizations statewide.

NA Meetings in West Virginia and Finding Help

Narcotics Anonymous meetings provide free, peer-led support for anyone with narcotic addiction or opioid abuse. NA meetings are available across West Virginia and take place every day in Charleston, Huntington, Morgantown, Parkersburg, Wheeling and many rural communities.

No matter your location in the country, NA meetings are close by. Feel free to check out our comprehensive directory or call 800-934-1582(Sponsored) to get started today.

The opioid crisis has found a new pipeline, and it fits in a teenager’s pocket. Dealers are increasingly using social media platforms including TikTok, Instagram and Snapchat to market and sell opioids directly to young people. The result: accelerating overdose deaths and deepening the reach of youth narcotic addiction across the country.

The Opioid Crisis Online

Over the past decade, the opioid epidemic has intensified as researchers have worked to understand what drives people toward opioids. They’ve learned that a  hidden digital marketplace has grown alongside the street trade.

Tim Mackey, a professor of Global Health at UC San Diego in California, has noted that children and young people face significantly higher risks of digital exposure to substance use disorder content and to illegal drug sales. Mackey describes the internet as a whole ecosystem where drug sellers operate across interconnected platforms.

The consequences are fatal. In 2020, 14-year-old Alex Neville was found dead by his mother after overdosing on illicit opioids he had obtained through Snapchat. His mother told a House panel in D.C. in 2023 that her son connected with dealers on Snapchat and arranged to obtain pills. The dealer was never caught and, despite the protests and outrage from parents of other kids who acquired drugs online, Snapchat never acknowledged its role in Alex’s death.

Algorithms & Addiction

Algorithms maximize user engagement, but amplify risky content. Videos referencing prescription painkillers might lead to new recommended posts for drug use, personal experiences or methods to obtain substances.

Dealers advertise pills using coded language, emojis or private messaging so that transactions occur out of plain sight, with many even taking place on the dark web. These tactics make it much easier for young people to access dangerous substances including opioids.

This pattern of exposure has normalized drug culture among youth and often shifts the drug culture to outpace official responses. Normalization can make opioid use appear more socially acceptable than it actually is. For many, that normalization is the first step toward opioid addiction. For some, it’s fatal.

Fentanyl’s Role in Social Media Drug Sales

What makes this digital pipeline uniquely deadly for teens is fentanyl. Pills sold through social media are frequently counterfeit. They look like legitimate prescriptions but laced with illicitly toxic fentanyl. A single pill is often lethal. Unlike heroin or prescription opioid abuse, where a person develops tolerance over time, fentanyl’s extreme potency means a first-time user can overdose without warning.

Mental health conditions, peer pressure and easy access often fuse with the digital environment to entice individuals to experiment with opioids. Tragically, many often have no idea that what they’re taking contains fentanyl.

Understanding Opioids and Overdose Risk

Opioids are a class of drugs that include prescription pain relievers such as oxycodone and hydrocodone, as well as illicit substances like heroin. They bind to receptors in the brain and body, producing pain relief and euphoria and in high doses, respiratory depression that can cause death.

If you or someone you love has an opioid or narcotic addiction, help and recovery are possible. Key resources include:

• Naloxone (Narcan): Widely available without a prescription at most pharmacies. Carry it, and know how to use it. It reverses opioid overdose and saves lives.

• Fentanyl test strips: Low-cost harm reduction tools that can detect fentanyl in any substance before use. They’re available through many local health departments and syringe service programs.

• Medication-Assisted Treatment (MAT): FDA-approved medications including buprenorphine, methadone and naltrexone are the standard of care for opioid use disorder. They reduce cravings and dramatically lower relapse.

• Narcotics Anonymous (NA): Free, peer-led recovery meetings for people struggling with narcotic addiction. NA meetings are available throughout the country, with in-person and online options.

Find NA Meetings and Opioid Treatment

NA is often the first (and ongoing) step that allows anyone to connect with peers in local communities. They’re free, confidential, and open to anyone with opioid or narcotic addiction, no matter their background. Dial 800-934-1582(Sponsored) or check out our directory for meetings in any location.